190 related articles for article (PubMed ID: 16917962)
1. Parvovirus B19 and immune disorders.
Pugliese A; Beltramo T; Torre D; Roccatello D
Cell Biochem Funct; 2007; 25(6):639-41. PubMed ID: 16917962
[TBL] [Abstract][Full Text] [Related]
2. A high prevalence of parvovirus B19 DNA in patients with psoriasis.
Yazici AC; Aslan G; Baz K; Ikizoglu G; Api H; Serin MS; Tezcan S; Emekdas G; Tasdelen B
Arch Dermatol Res; 2006 Oct; 298(5):231-5. PubMed ID: 16862431
[TBL] [Abstract][Full Text] [Related]
3. [Seroprevalence of anti-human parvovirus B19 antibodies in a sample of blood donors in Galicia].
Mata Rebón M; Bartolomé Husson C; Bernárdez Hermida I
Enferm Infecc Microbiol Clin; 1998 Jan; 16(1):25-7. PubMed ID: 9542305
[TBL] [Abstract][Full Text] [Related]
4. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis.
Kozireva SV; Zestkova JV; Mikazane HJ; Kadisa AL; Kakurina NA; Lejnieks AA; Danilane IN; Murovska MF
J Rheumatol; 2008 Jul; 35(7):1265-70. PubMed ID: 18484700
[TBL] [Abstract][Full Text] [Related]
5. Increased seroprevalence of parvovirus B 19 IgG in complex regional pain syndrome is not associated with antiendothelial autoimmunity.
Gross O; Tschernatsch M; Bräu ME; Hempelmann G; Birklein F; Kaps M; Madlener K; Blaes F
Eur J Pain; 2007 Feb; 11(2):237-40. PubMed ID: 16545972
[TBL] [Abstract][Full Text] [Related]
6. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
Uslu H; Kiki I; Ozbek A; Erdem F; Ayyildiz A
Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
8. [Systemic manifestations of Parvovirus B19 infections].
Sève P; Ferry T; Charhon A; Calvet A; Broussolle C
Rev Med Interne; 2004 Oct; 25(10):740-51. PubMed ID: 15471600
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.
Weissbrich B; Süss-Fröhlich Y; Girschick HJ
Arthritis Res Ther; 2007; 9(4):R82. PubMed ID: 17760961
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
Türk Dağı H; Ozdemir M; Baykan M; Baysal B
Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
[TBL] [Abstract][Full Text] [Related]
11. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
[TBL] [Abstract][Full Text] [Related]
12. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
Ohtsuka T; Yamazaki S
Br J Dermatol; 2004 Jun; 150(6):1091-5. PubMed ID: 15214893
[TBL] [Abstract][Full Text] [Related]
15. [Seroprevalence of B19 parvovirus infection in patients with acute polyarthritis].
Campoy Reolid E; Casanova Rituerto A; Rodríguez Moreno J; Gómez Vaquero C; Ros Expósito S; Roig Escofet D
Rev Clin Esp; 1996 Dec; 196(12):828-30. PubMed ID: 9132859
[TBL] [Abstract][Full Text] [Related]
16. Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway?
Aslanidis S; Pyrpasopoulou A; Kontotasios K; Doumas S; Zamboulis C
Eur J Intern Med; 2008 Jul; 19(5):314-8. PubMed ID: 18549931
[TBL] [Abstract][Full Text] [Related]
17. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.
Chen YS; Chou PH; Li SN; Tsai WC; Lin KH; Tsai KB; Yen JH; Liu HW
J Rheumatol; 2006 May; 33(5):887-91. PubMed ID: 16511938
[TBL] [Abstract][Full Text] [Related]
18. [Anti-GM1 and anti-sulphatide antibodies in systemic idiopathic vasculitis, systemic lupus erythematosus and mixed cryoglobulinaemia: Serum detection and clinical and electrophysiologic correlations].
Alpa M; Ferrero B; Cavallo R; Naretto C; Gennaro M; Bellizia L; Sena LM; Roccatello D
G Ital Nefrol; 2002; 19(6):617-21. PubMed ID: 12508165
[TBL] [Abstract][Full Text] [Related]
19. Human parvovirus B19 infection in children: uncommon clinical presentations.
Barash J; Dushnitzky D; Sthoeger D; Bardenstein R; Barak Y
Isr Med Assoc J; 2002 Oct; 4(10):763-5. PubMed ID: 12389336
[TBL] [Abstract][Full Text] [Related]
20. The relationship between arthritis and human parvovirus B19 infection.
Caliskan R; Masatlioglu S; Aslan M; Altun S; Saribas S; Ergin S; Uckan E; Koksal V; Oz V; Altas K; Fresko I; Kocazeybek B
Rheumatol Int; 2005 Nov; 26(1):7-11. PubMed ID: 15322815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]